Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

The Interdisciplinary Management and Safety Perspectives in Endocrine, Metabolic and Psychiatric Disorder

Author(s): Omar Cauli and Elsa Vitale

Volume 22, Issue 13, 2022

Published on: 21 October, 2022

Page: [1233 - 1234] Pages: 2

DOI: 10.2174/187153032213221021164256

Price: $65

conference banner
Next »
[1]
Vitale, E. Correlations between insomnia and sex, work experience, shift and body max index in italian nurses: A scoping profile statement. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1303-1312.
[2]
Vitale, E. A Chronic inflammatory inductive condition in the nursing profession: A scoping review. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1235-1244.
[3]
Antonino, C.; Vitale, E.; Lorenzo, B. Sex-Related differences linked to depression disorders and chronic inflammation diseases in nursing shift workers: an exploratory multidimensional literature review. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1293-1302.
[4]
Iovino, M.; Messana, T.; Lisco, G.; Mariano, F.; Giagulli, V.A.; Guastamacchia, E.; De Pergola, G.; Triggiani, V. Neuroendocrine modulation of food intake and eating behavior. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1252-1262.
[5]
Castellano, E.; Gaviglio, D.; Pellegrino, M.; Gianotti, L.; Magro, G.; Tassone, F.; Baffoni, C.; Sibbono, R.; Attanasio, R.; Boriano, A.; Borretta, G. A multi-professional approach for transition of care at discharge in hyperglycemic inpatients with covid-19: a single center study. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1313-1318.
[6]
Marucci, S.; De Iaco, G.; Lisco, G.; Mariano, F.; Giagulli, V.A.; Guastamacchia, E.; De Pergola, G.; Triggiani, V. Eating disorders and Type 1 diabetes: a perspective. Endocr. Metab. Immune Disord. Drug Targets, 2021, 22(13), 1245-1251.
[7]
Vecchia, G.F.D.; Hernandez, C.D.; Hirata, T.; Zhou, Y.; Lauschke, V.M.; Hirata, M.H.; Hirata, R. Pharmacogenomics of antihypertensive drugs in brazil: recent progress and clinical implications. Endocr. Metab. Immune Disord. Drug Targets, 2021, 22(13), 1263-1275.
[8]
Santa, K. Grape Phytochemicals and Vitamin D in Alleviation of Lung Disorders. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1276-1292.
[9]
Buigues, C.; Trapero, I.; De Velasco, J.A.; Salvador-Sanz, A.; Jennings, C.; Wood, D.; Queralt, A. Nurse-led and interdisciplinary secondary cardiovascular prevention programmes: Spanish cohort of the EUROACTION project. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(13), 1319-1329.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy